-
Tepezza Hearing Loss: Cases of This Drug Side Effect Reviewed in Various Medical Journal Articles
This Treatment for Thyroid Eye Disease Was Approved by FDA in 2020, With Hearing Problems Reported Soon Thereafter (Posted by Tom Lamb at Drug Injury Watch) We recently wrote about Tepezza hearing loss cases in…
-
Tepezza Hearing Side Effects Include Deafness, Sound Sensitivity, and Tinnitus, Resulting in Tepezza Drug Injury Lawsuits
Tepezza Linked to Hypoacusis, Hyperacusis, Autophony, Other Hearing Problems Which May be Irreversible and Permanent (Posted by Tom Lamb at Drug Injury Watch) Tepezza is a relatively new treatment for Thyroid Eye Disease, approved by…
-
Copiktra Risk-Benefit Profile Update Following the Recent September 2022 FDA Advisory Committee Meeting
Issue: Whether Copiktra Risk-Benefit Profile is Still Favorable as a Third-Line CLL/SLL Cancer Treatment; Final Vote: "No" (Posted by Tom Lamb at Drug Injury Watch) We concluded our July 5, 2022 article, "Using Copiktra for…
-
Byetta, Trulicity, Ozempic, and Adlyxin Linked to Gallbladder Disease Side Effects, Including Deaths
36 Cases of Acute Cholecystitis in Patients Taking Glucagon-like Peptide-1 (GLP-1) Receptor Agonists in FDA FAERS (Posted by Tom Lamb at Drug Injury Watch) A recent Research Letter written by three FDA employees with the…
-
Off-Topic News: Camp Lejeune Lawsuits for Cancers due to Contaminated Water During 1953-1987 Now Allowed
People Need to File a Federal Court Lawsuit in the Eastern District of North Carolina Before August 8, 2024 Filing Deadline (Posted by Tom Lamb at Drug Injury Watch) Veterans who served at Camp Lejeune…
-
Off-Topic Alert: Breast Implants Lymphoma Cancer ALCL Case Numbers Increasing Rapidly in the US
New Estimates Reported in July 2022 Medical Journal Article Reveal BIA-ALCL is Diagnosed More Often as Time Goes On (Posted by Tom Lamb at Drug Injury Watch) A research letter published July 21, 2022 in…
